RCT | Intermediate-dose no better than low-dose LMWH in pregnant and post-partum women with previous thromboembolism.

Intermediate-dose versus low-dose low-molecular-weight heparin in pregnant and post-partum women with a history of venous thromboembolism (Highlow study): an open-label, multicentre, randomised, controlled trial – The Lancet (link to abstract – $ for full-text)

Commentary from the author on Twitter (thread – click for more)

Intermediate-dose versus low-dose low-molecular-weight heparin in pregnant and post-partum women with a history of venous thromboembolism (Highlow study): an open-label, multicentre, randomised, controlled trial https://t.co/9zHeUIda7o

— Saskia Middeldorp (@MiddeldorpS) October 28, 2022